005690.KS

Pharmicell Co., Ltd. [005690.KS] Stock Forecast

Buy or Sell ? Support and Resistance

What is MACD and how to read it?

How RSI can help?
RSI : 000

005690.KS Stock Summary

Top 10 Correlated ETFs

005690.KS


Top 10 Correlated Stocks

005690.KS


In the News

005690.KS Financial details

Company Rating
Buy
Market Cap
343.22B
Income
-1.71B
Revenue
54.95B
Book val./share
-
Cash/share
-
Dividend
-
Dividend %
-
Employees
-
Optionable
No
Shortable
Yes
Earnings
05 Feb 2024
P/E
-194.07
Forward P/E
-
PEG
16.48
P/S
6.2
P/B
4.05
P/C
-
P/FCF
52.26
Quick Ratio
2.02
Current Ratio
3.41
Debt / Equity
0.06
LT Debt / Equity
0
-
-
EPS (TTM)
-28.05
EPS next Y
-
EPS next Q
-
EPS this Y
14.92%
EPS next Y
-
EPS next 5Y
-
EPS last 5Y
NAN%
Revenue last 5Y
16.25%
Revenue Q/Q
-31.42%
EPS Q/Q
78.4%
-
-
-
-
SMA20
-10.16%
SMA50
-25.07%
SMA100
-18.48%
Inst Own
-
Inst Trans
-
ROA
-2%
ROE
-2%
ROC
0.01%
Gross Margin
29%
Oper. Margin
1%
Profit Margin
-3%
Payout
-
Shs Outstand
60M
Shs Float
54.3M
-
-
-
-
Target Price
-
52W Range
5660.0-12100.0
52W High
-53.06%
52W Low
+0.35%
RSI
29
Rel Volume
-
Avg Volume
321.36K
Volume
Perf Week
-5.65%
Perf Month
-9.98%
Perf Quarter
-27.55%
Perf Half Y
-35.6%
-
-
-
-
Beta
-0.848
-
-
Volatility
84.76%, 336.28%
Prev Close
-0.7%
Price
5680
Change
-0.87%

005690.KS Financial Performance

Yearly Fundamentals Overview

Last date of statement is 2022-12-31

Metric History 2018-12-312019-12-312020-12-312021-12-31 2022-12-31
2.02K2.02K2.02K2.02K2.02K
Revenue per share
478.46545.46629.77850.841K
Net income per share
-2147387.44159.04181.58
Operating cash flow per share
57.46-1.27149.77-87.3132.03
Free cash flow per share
-21.47-29.18137.38-159.53-184.22
Cash per share
348.53315.68432.89605.92433.05
Book value per share
801.43865.15952.611.09K1.33K
Tangible book value per share
687.85746.65847.43988.311.23K
Share holders equity per share
801.43865.15952.611.09K1.33K
Interest debt per share
51.5953.4252.56316.49293.44
Market cap
758.48B505.58B1037.07B780.6B644.42B
Enterprise value
742.89B491.95B1019.19B771.63B646.9B
P/E ratio
-59.81116.3197.8582.0559.2
Price to sales ratio
26.7515.5627.4715.3410.71
POCF ratio
222.76-6.7K115.51-149.4881.42
PFCF ratio
-596.1-290.94125.93-81.8-58.35
P/B Ratio
15.979.8118.1611.948.08
PTB ratio
15.979.8118.1611.948.08
EV to sales
26.215.152715.1610.75
Enterprise value over EBITDA
348.89112.1131.1266.3747.27
EV to operating cash flow
218.18-6.52K113.52-147.7681.74
EV to free cash flow
-583.85-283.1123.76-80.86-58.58
Earnings yield
-0.020.010.010.010.02
Free cash flow yield
000.01-0.01-0.02
Debt to equity
0.060.060.050.260.21
Debt to assets
0.050.050.040.180.15
Net debt to EBITDA
-7.32-3.1-2.3-0.770.18
Current ratio
9.796.276.62.672.18
Interest coverage
4.5819.3885.214.5211.89
Income quality
-0.27-0.021.71-0.550.73
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.020.010.010.010.03
Research and developement to revenue
0.160.150.110.140.11
Intangibles to total assets
0.110.110.090.070.05
Capex to operating cash flow
-1.3722.02-0.080.83-2.4
Capex to revenue
-0.16-0.05-0.02-0.08-0.32
Capex to depreciation
-2.88-0.93-0.42-2.49-8.68
Stock based compensation to revenue
00000
Graham number
1.96K1.19K1.37K1.98K2.33K
ROIC
00.060.10.090.17
Return on tangible assets
-0.240.080.080.110.1
Graham Net
280.01309.37433.82431.43268.61
Working capital
29.21B29.13B36.43B41.58B33.82B
Tangible asset value
40.76B44.46B50.8B59.12B73.55B
Net current asset value
20.91B22.91B30.3B36.06B29.38B
Invested capital
0.060.060.050.260.21
Average receivables
6.78B8.09B11.19B14.07B15.52B
Average payables
891.39M832.01M1.29B1.4B1.75B
Average inventory
5.41B6.8B7.28B11.61B19.88B
Days sales outstanding
83.74108.74122.8110.7294.57
Days payables outstanding
23.4711.2636.0411.1426.66
Days of inventory on hand
118.57154.37115.83224.7229.47
Receivables turnover
4.363.362.973.33.86
Payables turnover
15.5532.4110.1332.7513.69
Inventory turnover
3.082.363.151.621.59
ROE
-0.270.080.090.150.14
Capex per share
-78.93-27.91-12.39-72.23-316.25

Quarterly Fundamentals Overview

Last date of statement is 2023-09-30 for Q3

Metric History 2022-09-302022-12-312023-03-312023-06-30 2023-09-30
2.02K2.02K2.02K2.02K2.02K
Revenue per share
287.88200.13225308.310
Net income per share
64.64-74.4818.59100
Operating cash flow per share
55.982.850.583.270
Free cash flow per share
-127.73-6.1841.6366.590
Cash per share
474.72435.48489.46527.340
Book value per share
1.38K1.34K1.38K1.41K0
Tangible book value per share
1.27K1.23K1.28K1.3K0
Share holders equity per share
1.38K1.34K1.38K1.41K0
Interest debt per share
315.16313.99289.22276.090
Market cap
617.44B640.83B531.79B428.73B0
Enterprise value
623.11B643.31B531.14B421.21B-14.1B
P/E ratio
39.84-36.08122.77186.250
Price to sales ratio
35.7853.7140.5824.160
POCF ratio
1843.84K180.889.470
PFCF ratio
-80.64-1.74K219.32111.890
P/B Ratio
7.498.046.615.290
PTB ratio
7.498.046.615.290
EV to sales
36.1153.9240.5323.74-1.16
Enterprise value over EBITDA
172.89-288.87136.41328.28-11.55
EV to operating cash flow
185.693.86K180.5887.9-7.51
EV to free cash flow
-81.38-1.75K219.05109.92-22.26
Earnings yield
0.01-0.01000
Free cash flow yield
-0.01000.010
Debt to equity
0.240.210.210.20.06
Debt to assets
0.170.150.150.140.04
Net debt to EBITDA
1.57-1.12-0.17-5.86-11.55
Current ratio
2.672.182.22.43.41
Interest coverage
-3.71-0.42-0.8200
Income quality
0.87-1.094.218.331.75
Dividend Yield
00000
Payout ratio
00000
Sales general and administrative to revenue
0.030.030.270.020.02
Research and developement to revenue
0.080.190.130.110.12
Intangibles to total assets
0.050.050.050.060.06
Capex to operating cash flow
-3.28-3.21-0.18-0.2-0.66
Capex to revenue
-0.64-0.04-0.04-0.05-0.1
Capex to depreciation
-18.04-0.75-0.74-1.36-1.76
Stock based compensation to revenue
00000
Graham number
1.41K1.5K760.1562.740
ROIC
0.04-0.0100.010.01
Return on tangible assets
0.04-0.040.010.010.01
Graham Net
385.75270.12260.78318.630
Working capital
41.59B33.82B34.68B35.26B35.84B
Tangible asset value
76.29B73.55B74.29B74.85B75.92B
Net current asset value
35.69B29.38B30.12B30.61B31.02B
Invested capital
0.240.210.210.20.06
Average receivables
21.88B19.1B13.28B10.13B9.87B
Average payables
2.8B2.97B2.79B2.39B2.21B
Average inventory
16.35B19.91B23.35B22.82B21.8B
Days sales outstanding
117.94117.6375.3747.1477.23
Days payables outstanding
26.3830.4628.6712.3226.88
Days of inventory on hand
136.51262.2232.93146.18227.3
Receivables turnover
0.760.771.191.911.17
Payables turnover
3.412.953.147.313.35
Inventory turnover
0.660.340.390.620.4
ROE
0.05-0.060.010.010.01
Capex per share
-183.71-8.98-8.87-16.680

005690.KS Frequently Asked Questions

What is Pharmicell Co., Ltd. stock symbol ?

Pharmicell Co., Ltd. is a KR stock and trading under the symbol 005690.KS

What is Pharmicell Co., Ltd. stock quote today ?

Pharmicell Co., Ltd. stock price is $5680 today.

Is Pharmicell Co., Ltd. stock public?

Yes, Pharmicell Co., Ltd. is a publicly traded company.

Something similar

Top by Market Cap
Top Correlated ETFs
Top Correlated Stocks
Similar Market Cap